跳转至内容
Merck
CN

20229

Supelco

ORBO 活性硅胶管

W,W,F separators, O.D. × L 6 mm × 75 mm, pkg of 50 ea

别名:

ORBO 52 小活化硅胶 (20/40) 150/75 mg,pk 50

登录查看公司和协议定价

选择尺寸


关于此项目

UNSPSC代码:
47131900
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

物料

W,W,F separators
silica gel

质量水平

Agency

NIOSH 2002,2003,2004,2005,2010,2013,2014
OSHA 16,21

产品线

ORBO

组成

Bed A, 150 mg
Bed B, 75 mg

包装

pkg of 50 ea

制造商/商品名称

ORBO 52 Small

技术

active air sampling: suitable

外径 × 长度

6 mm × 75 mm

基质

Activated silica gel

粒径

20-40 mesh

应用

air monitoring
environmental
industrial hygiene

正在寻找类似产品? 访问 产品对比指南

一般描述

  • ORBO 52 小活化硅胶 (20/40) 150/75 mg 溶剂解吸管设计用于气体和蒸汽取样。
  • 它包含两个由玻璃棉或泡沫分离的相同选择性吸附剂的床。
  • 双层结构或双床结构的球管允许在更小的备用床中捕获任何样本穿透。

法律信息

ORBO is a trademark of Sigma-Aldrich Co. LLC

储存分类代码

11 - Combustible Solids

WGK

nwg

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
Anne Beate Vereide et al.
Gynecologic oncology, 97(3), 740-750 (2005-05-12)
The aim of the study was to investigate apoptosis as a growth regulatory mechanism of gestagen in endometrial precancers and to compare differences in the apoptotic cascade after high and low dose gestagen regimens. Pre- and post-treatment paraffin-embedded endometrial hyperplasia

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持